Where does Celldex Therapeutics, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Celldex Therapeutics, Inc. ranks #9,226 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Celldex Therapeutics, Inc. hold?

Celldex Therapeutics, Inc. holds 34 US utility patents granted between 2015 and 2025, spanning 10 technology areas.

What is Celldex Therapeutics, Inc.'s Innovation Score?

Celldex Therapeutics, Inc. has an Innovation Score of 36.1 out of 100 (top 47% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Celldex Therapeutics, Inc. focus on?

Celldex Therapeutics, Inc.'s top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 32 patents, ranking #610 of 6,058 assignees active in that subclass. Grants appear in 10 CPC subclasses total.

Is Celldex Therapeutics, Inc.'s patent grant rate increasing or decreasing?

Celldex Therapeutics, Inc.'s recent grant velocity is +20% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Celldex Therapeutics, Inc.'s patents?

Celldex Therapeutics, Inc.'s patents average 14.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Celldex Therapeutics, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Celldex Therapeutics, Inc.

USPTO PatentsView assignee record - 34 granted patents across 10 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Celldex ranks #9,226 of 49,997 tracked US assignees by granted-patent volume, with 34 patents across 10 technology areas.

#9,226
of 49,997 US assignees by volume: Top 47%
by Innovation Score (36.1/100): 14.8
avg claims per patent: +20%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R9226 · US Corporation #9,226 · 34 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-UP · BOOK-FULL

GRANTS-SMALL 34 grants
UPPER-Q #9,226/49,997
PHOTO-FINISH Canary Medical
CPC-FOCUS A61P · 10 areas
INNOV-THIN 36.1/100
CLAIMS-RICH 14.8 claims/avg
TYPE-USCORP US Corporation
VEL-UP +20% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Canary Medical Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Celldex’s 36.1 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 12.3 pts (34%) Velocity 3.8 pts (10%) Breadth 11.2 pts (31%) Claim depth 8.9 pts (25%)

Qualcomm Incorporated · highest

85
Germans Boada · near

36
Brunson Instrument · near

36
Celldex Therapeutics · this assignee

36
DWS S R L · near

36
Elpis · near

36
3D Lighting… · lowest

7

What this shows Celldex's Innovation Score is 36.1/100 (top 47% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Celldex?

Each dot is one of Celldex’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Celldex’s own 14.8 claims/patent is at or below the 16.0 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Celldex vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Celldex's grants concentrate

Celldex Therapeutics, Inc. is a focused PatentsView assignee: 10 CPC subclasses with 94.1% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2020 (7 grants) versus a trough of 1 in 2023. By volume, Celldex sits between Canary Medical Inc. and Consolidated Metco, Inc..

Celldex's three-year grant acceleration

Celldex Therapeutics, Inc. shows 8 grants in 2022–2024 against only 14 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Canary Medical

34
Canon Information…

34
Canrig Robotic AS

34
Carebay Europe

34
Chien Luen Indust…

34
Clearone

34
Computime

34
Consolidated Metco

34
Celldex Therapeut… ◀

34

What this shows Celldex holds 34 patents at rank #9,232, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Celldex

By rank, the assignees closest to #9,232 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Celldex's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Celldex, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), Celldex ranks #610 of 6,058 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (36 here).

DWS S.R.L. 36 Elpis Technologies Inc. 36 Brunson Instrument Company 36 Germans Boada, S.A. 36

Celldex's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

36 Top 47% higher than 53% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Celldex Therapeutics, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	3	8.8%
2016	3	8.8%
2017	5	14.7%
2019	4	11.8%
2020	7	20.6%
2021	3	8.8%
2022	2	5.9%
2023	1	2.9%
2024	5	14.7%
2025partial year	1	2.9%

Which technologies does Celldex Therapeutics, Inc. patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 32

C07K - Peptides 32

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 32

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 11

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 6

C12Y - Enzymes 5

Y02A - Technologies FOR Adaptation TO Climate Change 2

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 1

A01K - Animal HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; Rearing OR Breeding Animals, NOT Otherwise Provided FOR; NEW Breeds OF Animals 1

A01N - Preservation OF Bodies OF Humans OR Animals OR Plants OR Parts Thereof ; Biocides, e.g. AS Disinfectants, AS Pesticides OR AS Herbicides ; Pest Repellants OR ATTRACTANTS; Plant Growth Regulators 1

Top 10 of 10 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Celldex Therapeutics, Inc.'s patent record in context - here's where to go next.

Celldex Therapeutics, Inc.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 94.1% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #9,226 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Celldex Therapeutics, Inc. against Canary Medical Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 36.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.